Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR path...
Q1 2026
May 15, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q3 2025
Nov 14, 2025
Q2 2025
Aug 5, 2025